Synthesis and in vitro antioxidant activity of some new fused pyridine analogs

Archiv der Pharmazie

Volumn 338, Issue 4, 2005, Pages 175-180

  Al Omar, Mohamed A ^a   Youssef, Khairia M ^a   El Sherbeny, Magda A ^a   Awadalla, Sit Albanat A ^b   El Subbagh, Hussein I ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Antioxidants; Fused pyridine analogs; Synthesis

Indexed keywords

CURCUMIN; FREE RADICAL; PYRANO[3,2 C]PYRIDINE DERIVATIVE; PYRAZOLO[4,3 C]PYRIDINE DERIVATIVE; PYRIDINE DERIVATIVE; PYRIDO[4,3 D]PYRIMIDINE DERIVATIVE; UNCLASSIFIED DRUG;

ANTIOXIDANT ACTIVITY; ARTICLE; DRUG POTENCY; DRUG SAFETY; DRUG SYNTHESIS; IN VITRO STUDY; NEUTROPHIL; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

ADENOSINE TRIPHOSPHATE; ANTIOXIDANTS; CHEMILUMINESCENT MEASUREMENTS; FREE RADICAL SCAVENGERS; HUMANS; INDICATORS AND REAGENTS; NEUTROPHILS; OXIDATION-REDUCTION; PYRIDINES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 19544375245     PISSN: 03656233     EISSN: None     Source Type: Journal    
DOI: 10.1002/ardp.200400953     Document Type: Article

References (23)

1. B. Halliwell, C. E. Cross, Environ. Health Perspect. 1994, 102, 5-10.
2. B. Halliwell, Pathol. Biol. (Paris) 1996, 44, 6-13.
3. R. A. Jacob, Nutr. Res. 1995, 15, 755-766.
4. Y. V. Yucan, D. D. Kitts in Natural antioxidants, chemistry, health effects and applications (Ed.: F. Shaihids), AOCS Press, Champaign, IL, 1997, pp. 258-270.
5. H. Sics, Exp. Physiol. 1997, 82, 291-295.
6. B. Halliwell, M. V. Clement, L. H. Long, FEBS Lett. 2000, 486, 10-13.
7. V. B. Djordjevic, Int. Rev. Cytol. 2004, 237, 57-89.
8. H. Wiseman, B. Halliwell, Biochem. J. 1996, 313, 17-29.
9. A. Gupta, S. F. Rosenberger, G. T. Bowden, Carcinogenesis 1999, 20, 2063-2073.
10. J. Regnstrom, J. Nilsson, P. Tomvall, C. Landou, A. Hamsten, Lancet 1992, 339, 1183-1186.
11. L. A. Shinobu, M. F. Beal in Metal and oxidative damage in neurological disorders (Ed.: J. R. Connor), Plenum Press, New York, NY, 1997, pp. 237-275.
12. N. Sreejayau, M. N. Rao, J. Pharm. Pharmacol. 1994, 46, 1013-1016.
13. M. I. Huang, Y.-R. Lou, J. G. Xie, W. Ma, Y. P. Lu, P. Yen, B. T. Zhu, H. Newmark, C. T. Ho, Carcinogenesis 1998, 19, 1697-1700.
14. K. Singletary, C. MacDonald, M. Iovincelli, C. Fisher, M. Wallig, Carcinogenesis 1998, 19, 1029-1043.
15. L. M. Antunes, J. D. Darin, M. Bianchi, Pharm. Res. 2001, 43, 145-150.
16. S. Sang, X. Cheng, R. E. Stark, R. T. Rosen, C. S. Yang, C. T. Ho, Bioorg. Med. Chem. 2002, 10, 2233-2237.
17. S. Sang, C. H. Liao, M. H. Pan, R. T. Rosen, S. L. Shiau, J. K. Lin, C. T. Ho, Tetrahedron 2002, 58, 10095-10102.
18. nd Edn., New York, NY, Oxford University Press. 1994, pp. 313-332.
19. K. M. Youssef, M. A. El-Sherbeny, F. A. El-Shafie, H. A. Farag, O. A. Al-Deeb, S. A. Awadalla, Arch. Pharm. Pharm. Med. Chem. 2004, 337, 42-54.
20. K. M. Youssef, M. A. El-Sherbeny, Arch. Pharm. Pharm. Med. Chem. 2005, in press.
21. H. I. El-Subbagh, S. M. Abu-Zaid, M. A. Mahran, F. A. Badria, A. M. Al-Obaid, J. Med. Chem. 2000, 43, 2915-2921.
22. A. S. Al-Tuwaijri, I. A. Al-Mofleh, A. A. Mahmoud, J. Med. Microbiol. 1990, 32, 189-193.
23. A. S. Al-Tuwaijri, A. A. Mustafa, Int. J. Immunopharmacol. 1992, 14, 83-91.